New Delhi: Coronavirus Live Updates: The trial of the Oxford vaccine was also stopped in India. The fire of Britain is also in India this time. Same formula. But multiple companies are developing vaccines. AstraZeneca is testing Oxford medicine in Britain. And in India, the vaccine is being made by the Pune Serum Institute.
On September 6, the third round of trials in Britain was abruptly called off due to the illness of a volunteer. Trials in the US, Brazil and South Africa were also hastily closed. But even on Wednesday, the Serum Institute did not close the trial.
Why the trial was not closed after the incident in Britain? The Drug Controller General of India (DGCI) sent a show-cause notice to the Serum Institute on this question. Why was the DGCI not informed of the decision to close the AstraZeneca trial? The question is why the trial is not being closed until the safety of the volunteers has been ensured in this notice? Question of DGCI.
After receiving the notice, the Serum Institute announced the decision to close the trial in a short statement. The trial is set to continue until a full review of the UK case is completed. Although sources said that a volunteer who fell ill in Britain had a spinal cord problem, another volunteer was diagnosed with a nerve problem in July and the trial was temporarily suspended.
People are again in the face of uncertainty as to the trial of the formula that was expected to get the corona antidote early next year is closed. Although AstraZeneca says this stumbling block is not likely to cause significant damage. The vaccine will come on the market within the proposed time ensuring complete protection.
📣 India Live Daily is now on Facebook. Click here to Like & Follow Our Facebook Page (@IndiaLiveDaily) and stay updated with the latest headlines.